Cognota, a Toronto-based learning operations software provider, raised $5.75 million in Series B funding led by Blossom Street Ventures to accelerate the development of AI agents.
PUBLIC · ENSCMar 12, 2026
Amount Raised
$5.75 Million
Round Type
Series B
La JollaManufacturingBiotechnologyHealthcareHardwareFinancial ServicesFinanceFintechLendingBanking
Investors
Comerica BankExisting InvestorsBlossom Street Ventures
Description
Cognota has successfully raised $5.75 million in Series B funding to further its development of AI agents and an intelligence layer. The funding round was led by Blossom Street Ventures, with participation from Comerica Bank and existing investors. This capital will help Cognota enhance its platform for learning operations. The company aims to align learning initiatives with overall business strategies.
Company Information
Company
Ensysce Biosciences
Location
7946 IVANHOE AVE
La Jolla, California, United States
About
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Fundz sees it the moment Ensysce Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
La JollaManufacturingBiotechnologyHealthcareHardwareFinancial ServicesFinanceFintechLendingBanking